Piccinni (PDF) - Fresenius Medical Care

Recommendations

Info

. . Grazie per l’attenzione l attenzione . .
Patogenesi dello Shock Settico e della MOF Insufficienza Multiorganica Citochine pro infiammatorie Citochine anti infiammatorie Prodotti di derivazione batterica (LPS, endotossine,esotossine) Complemento Mediatori Lipidici (PAF) M MOF F
Page 1 and 2:
CORSO AVANZATO PER MEDICI Trattamen
Page 3:
→ Il flusso ematico renale rappre
Page 6 and 7:
Factors that render the kidney susc
Page 8 and 9:
IRA: definizione L’IRA IRA è una
Page 10 and 11:
Incidenza dell’IRA dell IRA (Vinc
Page 12 and 13:
August 28-30, 28 30, 2000 New York
Page 14 and 15:
ORIGINAL INVESTIGATIONS The Outcome
Page 16 and 17:
Hospital Mortality Rate in RRT Pati
Page 18 and 19:
• IRA,frequente complicanza in IC
Page 20 and 21:
DIAGNOSES IN 544 PATIENTS WITH ARF
Page 22 and 23:
Acute Renal Failure in critically i
Page 24 and 25:
M.E. Ostermann, D. Taube, C.J. Morg
Page 26 and 27:
A higher level of knowledge needs t
Page 28 and 29:
Vivino G, Antonelli M, Moro ML, Cot
Page 30 and 31:
Risk factors increased by • Age
Page 32 and 33:
Agents and Events That Ameliorate o
Page 34 and 35:
Drugs Associated with Acute Renal F
Page 36 and 37:
RI=0.63 Renal Protection through st
Page 38 and 39:
A.de Mendonça, J.L. Vincent, P.M.
Page 40 and 41:
• Infection … they concluded th
Page 42 and 43:
De Mendonça A et al. Acute renal f
Page 44 and 45:
• Advanced age • Altered previo
Page 46 and 47:
Quale forma di IRA è frequentement
Page 48 and 49:
Sepsi: Stadi e definizioni Infezion
Page 50 and 51:
Arterial Vasodilatation and Renal V
Page 52 and 53:
Effect of Membrane Potential on the
Page 54 and 55:
good and bad effects of nitric oxid
Page 56 and 57:
FORMATION OF LPS/PROTEIN COMPLEXES
Page 58 and 59:
Tubular-Cell Injury and Repair in I
Page 60 and 61:
ACTIVATION OF HUMORAL PATHWAY L P S
Page 62 and 63:
A disorder due to incontrolled infl
Page 64 and 65:
The pathogenesis of septic acute re
Page 66 and 67:
Jo e colleghi hanno recentemente di
Page 68 and 69:
APOPTOSIS
Page 70 and 71: Acute renal failure Norbert Lameire
Page 73: 600 500 400 300 200 100 0 PaO2/FiO2
Page 77 and 78: ml/die 8000 7000 6000 5000 4000 300
Page 79 and 80: mg/dL 700 600 500 400 300 200 100 0
Page 81 and 82: Lasciato a se stesso e non contrast
Page 83 and 84: Strategie di protezione
Page 85 and 86: SEPSI E IRA Rilascio citochine,atti
Page 87 and 88: Renal Perfusion Pressure: Pressure
Page 89 and 90: • Riempimento volemico per manten
Page 91 and 92: Acute phase: Patients who have dila
Page 93 and 94: Cardiovascular changes associated w
Page 95 and 96: Dellinger RP. Crit Care Med 2003;31
Page 97 and 98: Edema removal by a dialysis techniq
Page 100: “independent independent from an
Page 103 and 104: …..guardando gli effetti biologic
Page 105 and 106: APOPTOSIS IN SEPSIS PHVHF decreased
Page 107 and 108: Terapia anti apoptosica? The Acute
Page 109 and 110: (%) Survival Rate of Early Vs Late
Page 112 and 113: EARLY ISOVOLEMIC HAEMOFILTRATION IN
Page 114 and 115: - Trattamento extracorporeo del san
Page 116 and 117: MOST Brain Liver mRNA/NfKb Cytokine
Page 118 and 119: Early detection of ARF,especially i
Page 122 and 123: The Response to Pathogens, Involvin
Page 125 and 126: Immunologic Response of Three Hypot
Page 127 and 128: Dal momento che la sepsi è un proc
Page 129: IMMUNOMODULAZIONE : Il goal della M
show all

Piccinni (PDF) - Fresenius Medical Care

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?